Literature DB >> 3110052

Transcriptional control of mu- and kappa-gene expression in resting and bacterial lipopolysaccharide-activated normal B cells.

U Chen-Bettecken, E Wecker, A Schimpl.   

Abstract

When murine resting B cells are polyclonally stimulated by bacterial lipopolysaccharide (LPS) in vitro for a short period of 4 days, they are activated to DNA synthesis and cell division, and they also differentiate to immunoglobulin (Ig)-secreting plasma cells. These two events are accompanied with several qualitative changes at the Ig mRNA level: the disappearance of delta mRNA after stimulation, the switch from membrane to secretory form of mu-mRNA, and the late appearance of IgM joining chain (J-chain) mRNA. There is also a quantitative increase of Ig-gene expression at the level of: Ig gene transcription, mu-, kappa- and J-chain mRNA accumulation, and Ig translation and secretion. A comparison of Ig transcription rates before and in the course of LPS stimulation, as determined by in vitro transcriptional run-on assays, has shown that there is a large increase of the RNA polymerase density on both mu- and kappa-loci (30-60-fold), which is quantitatively comparable with the accumulation of both mu- and kappa-mRNAs at the steady state mRNA level. These data therefore suggest that former results obtained with tumor cells regarding post-transcriptional control of Ig gene expression do not reflect the physiological behavior of normal B cells with respect to the molecular events of B cell triggering. We also propose that additional molecular events such as RNA processing and the transcriptional activation of J-chain gene might be essential for controlling the maximal transcriptional rate across the Ig loci.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3110052     DOI: 10.1016/s0171-2985(87)80036-0

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  13 in total

1.  The rapid generation of recombinant functional monoclonal antibodies from individual, antigen-specific bone marrow-derived plasma cells isolated using a novel fluorescence-based method.

Authors:  Alison M Clargo; Ashley R Hudson; Welcome Ndlovu; Rebecca J Wootton; Louise A Cremin; Victoria L O'Dowd; Carla R Nowosad; Dale O Starkie; Sophie P Shaw; Joanne E Compson; Dominic P White; Brendon MacKenzie; James R Snowden; Laura E Newnham; Michael Wright; Paul E Stephens; Meryn R Griffiths; Alastair D G Lawson; Daniel J Lightwood
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

2.  Characterization of a presecretory phase in B-cell differentiation.

Authors:  L B King; R B Corley
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

3.  Purified mu EBP-E binds to immunoglobulin enhancers and promoters.

Authors:  C L Peterson; S Eaton; K Calame
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

4.  Cross talk between immunoglobulin heavy-chain transcription and RNA surveillance during B cell development.

Authors:  Aurélien Tinguely; Guillaume Chemin; Sophie Péron; Christophe Sirac; Stéphane Reynaud; Michel Cogné; Laurent Delpy
Journal:  Mol Cell Biol       Date:  2011-10-28       Impact factor: 4.272

5.  Kappa immunoglobulin promoters and enhancers display developmentally controlled interactions.

Authors:  R Fulton; B Van Ness
Journal:  Nucleic Acids Res       Date:  1993-10-25       Impact factor: 16.971

6.  Selective synergy of immunoglobulin enhancer elements in B-cell development: a characteristic of kappa light chain enhancers, but not heavy chain enhancers.

Authors:  R Fulton; B van Ness
Journal:  Nucleic Acids Res       Date:  1994-10-11       Impact factor: 16.971

7.  Ex vivo characterization and isolation of rare memory B cells with antigen tetramers.

Authors:  Bettina Franz; Kenneth F May; Glenn Dranoff; Kai Wucherpfennig
Journal:  Blood       Date:  2011-05-06       Impact factor: 22.113

8.  A developmentally modulated chromatin structure at the mouse immunoglobulin kappa 3' enhancer.

Authors:  M C Roque; P A Smith; V C Blasquez
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

9.  XBP-1-deficient plasmablasts show normal protein folding but altered glycosylation and lipid synthesis.

Authors:  Annette M McGehee; Stephanie K Dougan; Elizabeth J Klemm; Guanghou Shui; Boyoun Park; You-Me Kim; Nicki Watson; Markus R Wenk; Hidde L Ploegh; Chih-Chi Andrew Hu
Journal:  J Immunol       Date:  2009-08-26       Impact factor: 5.422

10.  Anti-IgM antibodies down modulate mu-enhancer activity and OTF2 levels in LPS-stimulated mouse splenic B-cells.

Authors:  U Chen; R H Scheuermann; T Wirth; T Gerster; R G Roeder; K Harshman; C Berger
Journal:  Nucleic Acids Res       Date:  1991-11-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.